A Phase I, Open-Label Study of the Safety, Tolerability and Pharmacokinetics of RX108-A Tablet in Patients with Locally Advanced or Metastatic Solid Tumors
ACTRN 12623000307606 Brief Summary This study is investigating a new cancer treatment…
Read more arrow_forward